H.C. Wainwright increases NeuroPace's (NPCE) stock price target to $20 based on company guidance, indicating positive expectations for future performance.

H.C. Wainwright has increased its price target for NeuroPace (NPCE) to $20. This revision is based on the company's guidance, which suggests positive performance expectations in the near term. The bullish forecast may attract investor interest, potentially impacting NPCE's market performance. Analysts often adjust targets based on company guidance, making this development significant for current and prospective shareholders.

NeuroPace (NPCE) Stock Price Target Raised to $20 by H.C. Wainwright

AI Summary

Related News

Oklo Inc. (OKLO) Form 144 Filed on May 20, 2023

Watts Water Technologies (WTS) Shareholders Approve Annual Meeting Proposals

Oil Prices Drop Most in Two Weeks, Airlines Expected to Benefit

Credit Termites Impacting Bond Market and Portfolios